GlassScriptPhysician profile
Kyle J Oh
NPI 1699847590
$3,230.77
in general payments reported to CMS, 2019-2025
22 companies · $679 in 2025
The $679 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $670 · 2021: $676 · 2022: $384 · 2023: $161 · 2024: $403 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $633.79 | 2021-2025 | Zubsolv |
| Collegium Pharmaceutical, INC. | $564.01 | 2023-2025 | Xtampza, Belbuca |
| Titan Pharmaceuticals, INC. | $437.43 | 2019-2020 | |
| Abbvie INC. | $348.72 | 2021-2024 | |
| Pfizer INC. | $315.18 | 2020-2024 | |
| Lilly USA, LLC | $234.43 | 2019-2021 | |
| Allergan, INC. | $93.02 | 2020 | |
| Indivior INC. | $84.55 | 2019-2024 | Sublocade |
| Amgen INC. | $72.24 | 2022 | |
| Daiichi Sankyo INC. | $67.53 | 2019 | |
| Boston Scientific Corporation | $57.34 | 2021 | |
| Virtus Pharmaceuticals LLC | $55.02 | 2021-2024 | Levorphanol Tartrate |
| Si-Bone, INC. | $51.74 | 2021 | |
| Idorsia Pharmaceuticals US INC | $37.03 | 2023 | Quviviq |
| Redhill Biopharma INC. | $34.05 | 2020-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $28.39 | 2023 | Brixadi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.99 | 2025 | Relistor |
| Eisai INC. | $24.42 | 2020 | |
| Medtronic USA, INC. | $23.51 | 2019 | |
| Protega Pharmaceutials INC | $16.90 | 2025 | Roxybond |
| Abbott Laboratories | $13.69 | 2019 | |
| Biodelivery Sciences International, INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.